- Home
- WAL vs KZR Comparison
WAL vs KZR Comparison
Compare WAL & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WAL | KZR |
|---|---|---|
| Founded | 1994 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7B | 45.8M |
| IPO Year | 2005 | 2018 |
Fundamental Metrics
Financial Performance| Metric | WAL | KZR |
|---|---|---|
| Price | $84.52 | $6.26 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 4 |
| Target Price | ★ $99.64 | $6.00 |
| AVG Volume (30 Days) | ★ 847.2K | 30.5K |
| Earning Date | 01-26-2026 | 11-12-2025 |
| Dividend Yield | ★ 1.80% | N/A |
| EPS Growth | ★ 24.99 | N/A |
| EPS | ★ 8.09 | N/A |
| Revenue | ★ $3,189,400,000.00 | N/A |
| Revenue This Year | $16.21 | N/A |
| Revenue Next Year | $9.07 | N/A |
| P/E Ratio | $10.46 | ★ N/A |
| Revenue Growth | ★ 9.57 | N/A |
| 52 Week Low | $57.05 | $3.53 |
| 52 Week High | $94.40 | $6.93 |
Technical Indicators
Market Signals| Indicator | WAL | KZR |
|---|---|---|
| Relative Strength Index (RSI) | 50.10 | 52.34 |
| Support Level | $85.14 | $6.22 |
| Resistance Level | $88.09 | $6.35 |
| Average True Range (ATR) | 1.63 | 0.10 |
| MACD | -0.45 | -0.03 |
| Stochastic Oscillator | 12.36 | 40.91 |
Price Performance
Historical ComparisonAbout WAL Western Alliance Bancorporation (DE)
Western Alliance Bancorporation is a Las Vegas-based holding company with regional banks operating in Nevada, Arizona, and California. The bank offers retail banking services and focuses on mortgages for retail customers and commercial loans. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.